Ebit تغيير تاريخ
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 2.13B 281M 2026-06
ALKERMES USD -65.93M 17.65M 2026-06
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Coherus Biosciences USD -39.08M 3.65M 2025-12
Drreddys Laboratories INR 3.05B 13.32B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
J&J USD 7.48B 860M 2026-06
Medtronic USD 2.09B 354M 2026-03
Merck USD -1.88B 8.12B 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 2.18B 1.56B 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Zoetis USD 842M 7M 2026-03